A Combined Approach Identifies Three MRNAs That Are Down-regulated by MicroRNA-29b and Promote Invasion Ability in the Breast Cancer Cell Line MCF-7

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 2012 Aug 7

PMID 22864815

Citations 25

Authors

Chen Wang

Chao Gao

Jun-Long Zhuang

Chao Ding

Yong Wang

Affiliations

Soon will be listed here.

Abstract

Background And Aims: MicroRNAs (miRNAs) are short noncoding RNAs that regulate gene expression by targeting mRNAs. Our previous study found that miR-29b strongly regulates the migration and invasion of breast cancer cells. Here, we aimed to identify the mRNAs targeted by miR-29b.

Methods: We used microarray experiments in conjunction with computational methods to identify the mRNAs that were most susceptible to miR-29b-mediated repression. We further confirmed the activities of three target genes, C1QTNF6, SPARC, and COL4A2, by luciferase reporter analyses and invasion assays.

Results: We evaluated the impact of miR-29b on global mRNA expression in MCF-7 human breast cancer cells through microarray analysis and further analyzed four genes that were at least twofold down-regulated and predicted as miR-29b targets by at least two of the four widely used miRNA target prediction algorithms. We also analyzed one mRNA that was down-regulated by 1.8-fold but was predicted to have significant interactions with miR-29b in pathway analysis and was predicted as a miR-29b target by all four algorithms. Luciferase reporter and invasion assays revealed that C1QTNF6, SPARC, and COL4A2 were targeted by miR-29b and that the degradation of any one of these mRNAs could promote invasion in MCF-7 cells.

Conclusions: C1QTNF6, SPARC, and COL4A2 are targeted by miR-29b, and the down-regulation of these three mRNAs can contribute to the invasion ability of MCF-7 cells.

Citing Articles

Unveiling Collagen's Role in Breast Cancer: Insights into Expression Patterns, Functions and Clinical Implications.

Li X, Jin Y, Xue J Int J Gen Med. 2024; 17:1773-1787.

PMID: 38711825 PMC: 11073151. DOI: 10.2147/IJGM.S463649.

Unraveling the Multifaceted Role of the miR-17-92 Cluster in Colorectal Cancer: From Mechanisms to Biomarker Potential.

Al-Nakhle H Curr Issues Mol Biol. 2024; 46(3):1832-1850.

PMID: 38534736 PMC: 10969598. DOI: 10.3390/cimb46030120.

Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence.

Reid S, Pantaleo J, Bolivar P, Bocci M, Sjolund J, Morsing M Oncogene. 2024; 43(15):1113-1126.

PMID: 38388711 PMC: 10997519. DOI: 10.1038/s41388-024-02973-x.

Molecular regulatory mechanism of key LncRNAs in subclinical mastitic cows with folic acid supplementation.

Liu X, Mi S, Li W, Zhang J, Augustino S, Zhang Z BMC Genomics. 2023; 24(1):464.

PMID: 37592228 PMC: 10436419. DOI: 10.1186/s12864-023-09466-3.

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation.

Natkin R, Pennanen P, Syvala H, Blauer M, Kesseli J, Tammela T PLoS One. 2023; 18(2):e0281645.

PMID: 36809527 PMC: 9942993. DOI: 10.1371/journal.pone.0281645.

References

Dumont N, Tlsty T . Reflections on miR-ing effects in metastasis. Cancer Cell. 2009; 16(1):3-4. DOI: 10.1016/j.ccr.2009.06.013. View

Koblinski J, Kaplan-Singer B, VanOsdol S, Wu M, Engbring J, Wang S . Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res. 2005; 65(16):7370-7. DOI: 10.1158/0008-5472.CAN-05-0807. View

Stefani G, Slack F . Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008; 9(3):219-30. DOI: 10.1038/nrm2347. View

Cortes-Reynosa P, Robledo T, Macias-Silva M, Wu S, Salazar E . Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol. 2007; 27(3):220-31. DOI: 10.1016/j.matbio.2007.11.003. View

Wang C, Bian Z, Wei D, Zhang J . miR-29b regulates migration of human breast cancer cells. Mol Cell Biochem. 2011; 352(1-2):197-207. DOI: 10.1007/s11010-011-0755-z. View

Sood P, Krek A, Zavolan M, Macino G, Rajewsky N . Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A. 2006; 103(8):2746-51. PMC: 1413820. DOI: 10.1073/pnas.0511045103. View

Filipowicz W, Bhattacharyya S, Sonenberg N . Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet. 2008; 9(2):102-14. DOI: 10.1038/nrg2290. View

Lewis B, Shih I, Jones-Rhoades M, Bartel D, Burge C . Prediction of mammalian microRNA targets. Cell. 2003; 115(7):787-98. DOI: 10.1016/s0092-8674(03)01018-3. View

Sahab Z, Hall M, Sung Y, Dakshanamurthy S, Ji Y, Kumar D . Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle. Cancer Res. 2011; 71(4):1219-28. PMC: 3062087. DOI: 10.1158/0008-5472.CAN-10-2294. View

10.

Iorio M, Ferracin M, Liu C, Veronese A, Spizzo R, Sabbioni S . MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65(16):7065-70. DOI: 10.1158/0008-5472.CAN-05-1783. View

11.

Roderburg C, Urban G, Bettermann K, Vucur M, Zimmermann H, Schmidt S . Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2010; 53(1):209-18. DOI: 10.1002/hep.23922. View

12.

Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N . Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. 2009; 391(1):316-21. DOI: 10.1016/j.bbrc.2009.11.056. View

13.

Mizukami S, Ichimura R, Kemmochi S, Taniai E, Shimamoto K, Ohishi T . Induction of GST-P-positive proliferative lesions facilitating lipid peroxidation with possible involvement of transferrin receptor up-regulation and ceruloplasmin down-regulation from the early stage of liver tumor promotion in rats. Arch Toxicol. 2010; 84(4):319-31. DOI: 10.1007/s00204-009-0496-x. View

14.

Hurst D, Edmonds M, Welch D . Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res. 2009; 69(19):7495-8. PMC: 2756311. DOI: 10.1158/0008-5472.CAN-09-2111. View

15.

Takeuchi T, Adachi Y, Nagayama T . Expression of a secretory protein C1qTNF6, a C1qTNF family member, in hepatocellular carcinoma. Anal Cell Pathol (Amst). 2011; 34(3):113-21. PMC: 4605662. DOI: 10.3233/ACP-2011-009. View

16.

Sengupta S, den Boon J, Chen I, Newton M, Stanhope S, Cheng Y . MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A. 2008; 105(15):5874-8. PMC: 2311339. DOI: 10.1073/pnas.0801130105. View

17.

Luna C, Li G, Qiu J, Epstein D, Gonzalez P . Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress. Mol Vis. 2009; 15:2488-97. PMC: 2786891. View

18.

Mattie M, Benz C, Bowers J, Sensinger K, Wong L, Scott G . Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 2006; 5:24. PMC: 1563474. DOI: 10.1186/1476-4598-5-24. View

19.

Eyholzer M, Schmid S, Wilkens L, Mueller B, Pabst T . The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br J Cancer. 2010; 103(2):275-84. PMC: 2906742. DOI: 10.1038/sj.bjc.6605751. View

20.

Zhdanov V . Conditions of appreciable influence of microRNA on a large number of target mRNAs. Mol Biosyst. 2009; 5(6):638-43. DOI: 10.1039/b808095j. View